Search Results - "Whitlock, Reid H"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Impact of a Medical Fitness Model on Incident Major Adverse Cardiovascular Events: A Prospective Cohort Study of 11 000 Members by Brar, Ranveer, Whitlock, Reid H, Katz, Alan, Di Nella, Michelle, Komenda, Paul, Bohm, Clara, Rigatto, Claudio, Tangri, Navdeep, Solmundson, Carrie, Collister, David

    Published in Journal of the American Heart Association (02-04-2024)
    “…Cardiovascular disease remains the leading cause of disease burden and death in the world. The medical fitness model may be an alternative public health…”
    Get full text
    Journal Article
  2. 2

    Long term health outcomes in patients with a history of myocardial infarction: A population based cohort study by Tangri, Navdeep, Ferguson, Thomas W, Whitlock, Reid H, Rigatto, Claudio, Jassal, Davinder S, Kass, Malek, Toleva, Olga, Komenda, Paul

    Published in PloS one (12-07-2017)
    “…Myocardial infarction (MI) is associated with high morbidity and mortality, particularly in the first 12 months post-event. Interventions such as dual…”
    Get full text
    Journal Article
  3. 3

    Magnitude of the Potential Screening Gap for Fabry Disease in Manitoba: A Population-Based Retrospective Cohort Study by Whitlock, Reid H., Nour-Mohammadi, Mohammad, Curtis, Sarah, Komenda, Paul, Bohm, Clara, Collister, David, Tangri, Navdeep, Rigatto, Claudio

    “…Background: Fabry disease is a rare disorder caused by the deficient activity of α-galactosidase A (GLA) that often leads to organ damage. Fabry disease can be…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Validation of the Kidney Failure Risk Equation in Manitoba by Whitlock, Reid H., Chartier, Mariette, Komenda, Paul, Hingwala, Jay, Rigatto, Claudio, Walld, Randy, Dart, Allison, Tangri, Navdeep

    “…Background: Patients with chronic kidney disease (CKD) are at risk to progress to kidney failure. We previously developed the Kidney Failure Risk Equation…”
    Get full text
    Journal Article
  6. 6

    Acute Kidney Injury Events in Patients With Type 2 Diabetes Using SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs: A Retrospective Cohort Study by Rampersad, Christie, Kraut, Eyal, Whitlock, Reid H., Komenda, Paul, Woo, Vincent, Rigatto, Claudio, Tangri, Navdeep

    Published in American journal of kidney diseases (01-10-2020)
    “…Sodium/glucose cotransporter 2 (SGLT2) inhibitors slow the progression of chronic kidney disease and prevent heart failure events. However, SGLT2 inhibitors…”
    Get full text
    Journal Article
  7. 7

    A Safety Comparison of Metformin vs Sulfonylurea Initiation in Patients With Type 2 Diabetes and Chronic Kidney Disease: A Retrospective Cohort Study by Whitlock, Reid H., Hougen, Ingrid, Komenda, Paul, Rigatto, Claudio, Clemens, Kristin K., Tangri, Navdeep

    Published in Mayo Clinic proceedings (01-01-2020)
    “…To compare the safety of metformin vs sulfonylureas in patients with type 2 diabetes by chronic kidney disease (CKD) stage. This retrospective cohort study…”
    Get full text
    Journal Article
  8. 8

    The Fracture Risk Assessment Tool (FRAX®) predicts fracture risk in patients with chronic kidney disease by Whitlock, Reid H, Leslie, William D, Shaw, James, Rigatto, Claudio, Thorlacius, Laurel, Komenda, Paul, Collister, David, Kanis, John A, Tangri, Navdeep

    Published in Kidney international (01-02-2019)
    “…The Fracture Risk Assessment Tool (FRAX®) was developed to predict fracture risk in the general population, but its applicability to patients with chronic…”
    Get more information
    Journal Article
  9. 9

    Provider Perception of Frailty Is Associated with Dialysis Decision Making in Patients with Advanced CKD by Brar, Ranveer S, Whitlock, Reid H, Komenda, Paul V J, Rigatto, Claudio, Prasad, Bhanu, Bohm, Clara, Tangri, Navdeep

    “…Frailty is common in patients with CKD. Little is known about the prevalence of frailty and its effect on prognosis and decisions surrounding dialysis…”
    Get full text
    Journal Article
  10. 10

    Metabolic acidosis is undertreated and underdiagnosed: a retrospective cohort study by Whitlock, Reid H, Ferguson, Thomas W, Komenda, Paul, Rigatto, Claudio, Collister, David, Bohm, Clara, Reaven, Nancy L, Funk, Susan E, Tangri, Navdeep

    Published in Nephrology, dialysis, transplantation (31-05-2023)
    “…ABSTRACT Background Guidelines recommend treatment of metabolic acidosis (MA) in patients with chronic kidney disease (CKD), but the diagnosis and treatment…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Safety of add-on sulfonylurea therapy in patients with type 2 diabetes using metformin: a population-based real-world study by Hougen, Ingrid, Whitlock, Reid H, Komenda, Paul, Rigatto, Claudio, Clemens, Kristin K, Tangri, Navdeep

    Published in BMJ open diabetes research & care (01-12-2021)
    “…IntroductionMetformin is the initial oral antihyperglycemic agent (OHA) of choice for most patients with type 2 diabetes (T2D). However, more than one agent is…”
    Get full text
    Journal Article
  13. 13

    Association of serum bicarbonate with the development of kidney stones in patients with chronic kidney disease: a retrospective cohort study by Tangri, Navdeep, Mathur, Vandana, Reaven, Nancy L, Funk, Susan E, Whitlock, Reid H, Wesson, Donald E, Bushinsky, David A

    Published in Clinical kidney journal (01-07-2023)
    “…Background Epidemiological studies demonstrate an association between kidney stones and risk of chronic kidney disease (CKD) and CKD progression. Metabolic…”
    Get full text
    Journal Article
  14. 14

    Cost-Utility of Dialysis in Canada: Hemodialysis, Peritoneal Dialysis, and Nondialysis Treatment of Kidney Failure by Ferguson, Thomas W., Whitlock, Reid H., Bamforth, Ryan J., Beaudry, Alain, Darcel, Joseph, Di Nella, Michelle, Rigatto, Claudio, Tangri, Navdeep, Komenda, Paul

    Published in Kidney medicine (01-01-2021)
    “…The kidney failure population is growing, necessitating the expansion of dialysis programs. These programs are costly and require a substantial amount of…”
    Get full text
    Journal Article
  15. 15

    Metabolic Acidosis is Associated With Acute Kidney Injury in Patients With CKD by Zhu, Antonia, Whitlock, Reid H., Ferguson, Thomas W., Nour-Mohammadi, Mohammad, Komenda, Paul, Rigatto, Claudio, Collister, David, Bohm, Clara, Reaven, Nancy L., Funk, Susan E., Tangri, Navdeep

    Published in Kidney international reports (01-10-2022)
    “…Metabolic acidosis in patients with chronic kidney disease (CKD) results from a loss of kidney function. It has been associated with CKD progression, all-cause…”
    Get full text
    Journal Article
  16. 16

    A Cost-Minimization Analysis of Nurse-Led Virtual Case Management in Late-Stage CKD by Ferguson, Thomas W., Hager, Drew, Whitlock, Reid H., Di Nella, Michelle, Tangri, Navdeep, Komenda, Paul, Rigatto, Claudio

    Published in Kidney international reports (01-06-2020)
    “…Interventions are needed to improve early detection of indications for dialysis before development of severe symptoms or complications. This may reduce…”
    Get full text
    Journal Article
  17. 17

    A before and after cross-sectional analysis of a public health campaign to increase kidney health awareness in a Canadian province by Ryz, Krista, Tangri, Navdeep, Verrelli, Mauro, Schneider, Jan, Lesyk, Amie, Eng, Amanda, Hiebert, Brett, Whitlock, Reid H, Sood, Manish M, Rigatto, Claudio, Komenda, Paul

    Published in BMC research notes (20-11-2015)
    “…Chronic kidney disease (CKD) has a major impact on patient health and health system resources. The prevalence of kidney disease is increasing, with Manitoba…”
    Get full text
    Journal Article
  18. 18

    Cost-Utility of Dialysis in Canada: Hemodialysis, Peritoneal Dialysis, and Nondialysis Treatment of Kidney FailurePlain-Language Summary by Thomas W. Ferguson, Reid H. Whitlock, Ryan J. Bamforth, Alain Beaudry, Joseph Darcel, Michelle Di Nella, Claudio Rigatto, Navdeep Tangri, Paul Komenda

    Published in Kidney medicine (01-01-2021)
    “…Rationale & Objective: The kidney failure population is growing, necessitating the expansion of dialysis programs. These programs are costly and require a…”
    Get full text
    Journal Article